# Atara (ATRA) — News

ATRA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/atra/news

## Recent headlines

- [Atara Biotherapeutics - Eligible for $31 mln milestone payment if Tabelecleucel approved](https://www.ainvest.com/news/atara-biotherapeutics-eligible-31-mln-milestone-payment-tabelecleucel-approved-2610) — AInvest Wire, Oct 14, 2026
- [Atara's tab-cel BLA resubmission accepted by FDA](https://www.ainvest.com/news/atara-tab-cel-bla-resubmission-accepted-fda-2610) — AInvest Wire, Oct 14, 2026
  U.S. regulatory authorities have accepted Atara Biotherapeutics’ resubmission of the Biologics License Application (BLA) for Tab-cel, a cell therapy intended for the treatment of Epstein-Barr virus (EBV)-positive post-transplant lymphoproliferative disorder (PTLD). The acceptance follows the…
- [Atara Biotherapeutics - PDUFA target action date for Tabelecleucel is March 31, 2027](https://www.ainvest.com/news/atara-biotherapeutics-pdufa-target-action-date-tabelecleucel-march-31-2027-2610) — AInvest Wire, Oct 14, 2026
- [Atara's Tablelcleucel BLA resubmitted to FDA](https://www.ainvest.com/news/atara-tablelcleucel-bla-resubmitted-fda-2609) — AInvest Wire, Sep 30, 2026
- [Atara Biotherapeutics reports that the Tabelecleucel biologics license application has been resubmitted to the U.S. Food and Drug Administration](https://www.ainvest.com/news/atara-biotherapeutics-reports-tabelecleucel-biologics-license-application-resubmitted-food-drug-administration-2609) — AInvest Wire, Sep 30, 2026
  Atara Biotherapeutics, Inc. (Nasdaq: ATRA) announced that Pierre Fabre Pharmaceuticals, Inc. (PFP), the U.S. subsidiary of Pierre Fabre Laboratories, has engaged in discussions with the U.S. Food and Drug Administration (FDA) following the receipt of a Complete Response Letter (CRL) for the…

## Similar Stocks

- [ORIC](https://www.lighthorse.io/tickers/oric) — Oric Pharmaceuticals, Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).